Apyx Medical Corporation Reports Fourth Quarter and Full Year of 2019 Preliminary Unaudited Financial Results and Introduces First Quarter of Fiscal Year 2020 Financial Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Apyx Medical Corporation Reports Fourth Quarter and Full Year of 2019 Preliminary Unaudited Financial Results and Introduces First Quarter of Fiscal Year 2020 Financial Outlook

Apyx Medical Corp. (APYX) Tops Q4 EPS by 3c, Revenues beat; Offers Q1 Revenue Guidance Below Consensus

March 16, 2020 4:11 PM EDT

Apyx Medical Corp. (NASDAQ: APYX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $8.38 million versus the consensus estimate of $7.86 million.

Fourth Quarter 2019 Financial Summary:

Total Q4 revenue from continuing operations of $8.4 million, up 41% year-over-year.Advanced Energy revenue of $6.9 million, up 58% year-over-year.OEM revenue of $1.5 million, down 4% year-over-year.Total Q4 GAAP net loss from continuing operations of $5.4 million versus total GAAP net loss from continuing operations of $3.9 million for the fourth quarter of 2018.Total Q4 adjusted EBITDA loss from... More